A board to discuss future MS therapies in early stage (Phase I or II) trials.


Postby bromley » Sat Mar 25, 2006 8:22 am

This is one of the drugs in the pipeline at Neuren. It is a neuro-protective drug and pre-clinical results look promising. I think it has just entered into Phase 1 human trials.

See 22 March news on the company's website.

Let's hope that the human trial results are as good

<shortened url>
User avatar
Family Elder
Posts: 1887
Joined: Fri Sep 10, 2004 3:00 pm

Return to Drug Pipeline


  • Related topics
    Last post
  • NNZ-2566
    by bromley » Mon Mar 06, 2006 11:44 am
    0 Replies
    Last post by bromley View the latest post
    Mon Mar 06, 2006 11:44 am

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service